Twenty-five years of palivizumab: a global historic review of its impact on the burden of respiratory syncytial virus disease in children.

Carbonell-Estrany X, Simões EAF, Bont L, Manzoni P, Zar HJ, Greenough A, Ramilo O, Stein R, Law B, Mejias A, Sanchez Luna M, Checchia PA, Krilov L, Lanari M, Dagan R, Fauroux B, Resch B, Heikkinen T, Domachowske JB, Wildenbeest JG, Martinon-Torres F, Thwaites R, Cetinkaya M, Alharbi AS, Rodriguez-Martinez CE, Noyola DE, Kassim A, Kusuda S, Kang JM, Rodgers-Gray B, Platonova A, Jah F, Paes B

Open source

DOI: 10.1080/14787210.2025.2481908
Published: 2025 Jun
Container: Expert review of anti-infective therapy
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/14787210.2025.2481908,
  title = {Twenty-five years of palivizumab: a global historic review of its impact on the burden of respiratory syncytial virus disease in children.},
  author = {Carbonell-Estrany X and Simões EAF and Bont L and Manzoni P and Zar HJ and Greenough A and Ramilo O and Stein R and Law B and Mejias A and Sanchez Luna M and Checchia PA and Krilov L and Lanari M and Dagan R and Fauroux B and Resch B and Heikkinen T and Domachowske JB and Wildenbeest JG and Martinon-Torres F and Thwaites R and Cetinkaya M and Alharbi AS and Rodriguez-Martinez CE and Noyola DE and Kassim A and Kusuda S and Kang JM and Rodgers-Gray B and Platonova A and Jah F and Paes B},
  year = {2025},
  journal = {Expert review of anti-infective therapy},
  doi = {10.1080/14787210.2025.2481908},
  url = {https://doi.org/10.1080/14787210.2025.2481908}
}

RIS

TY  - JOUR
TI  - Twenty-five years of palivizumab: a global historic review of its impact on the burden of respiratory syncytial virus disease in children.
AU  - Carbonell-Estrany X
AU  - Simões EAF
AU  - Bont L
AU  - Manzoni P
AU  - Zar HJ
AU  - Greenough A
AU  - Ramilo O
AU  - Stein R
AU  - Law B
AU  - Mejias A
AU  - Sanchez Luna M
AU  - Checchia PA
AU  - Krilov L
AU  - Lanari M
AU  - Dagan R
AU  - Fauroux B
AU  - Resch B
AU  - Heikkinen T
AU  - Domachowske JB
AU  - Wildenbeest JG
AU  - Martinon-Torres F
AU  - Thwaites R
AU  - Cetinkaya M
AU  - Alharbi AS
AU  - Rodriguez-Martinez CE
AU  - Noyola DE
AU  - Kassim A
AU  - Kusuda S
AU  - Kang JM
AU  - Rodgers-Gray B
AU  - Platonova A
AU  - Jah F
AU  - Paes B
PY  - 2025
JO  - Expert review of anti-infective therapy
DO  - 10.1080/14787210.2025.2481908
UR  - https://doi.org/10.1080/14787210.2025.2481908
ER  -

APA

X, C., EAF, S., L, B., P, M., HJ, Z., A, G., O, R., R, S., B, L., A, M., M, S. L., PA, C., L, K., M, L., R, D., B, F., B, R., T, H., JB, D., JG, W., F, M., R, T., M, C., AS, A., CE, R., DE, N., A, K., S, K., JM, K., B, R., A, P., F, J., & B, P. (2025). Twenty-five years of palivizumab: a global historic review of its impact on the burden of respiratory syncytial virus disease in children.. Expert review of anti-infective therapy. https://doi.org/10.1080/14787210.2025.2481908

Source records

pubmed · retrieved 2026-09-26T16:43:08.146Z